Key Points • Real-world evidence (RWE) studies are gaining relevance in the clinical development programmes of drugs for advanced cancer. • RWE studies of drugs for advanced cancer can be challenging because the study drug can be part of several of the many lines of treatment (LoTs) patients can receive, and occasionally, the component drugs of a LoT are not started concomitantly. • The target trial emulation framework can help in the design, analysis, and interpretation of RWE studies of drugs for advanced cancer.
Design considerations for observational studies of drugs for advanced cancer
X. García-Albéniz,P. Stattin,M. Westerberg,R. Weinrib,Per Sandstrom,Z. Vassilev
Published 2023 in Pharmacoepidemiology and Drug Safety
ABSTRACT
PUBLICATION RECORD
- Publication year
2023
- Venue
Pharmacoepidemiology and Drug Safety
- Publication date
2023-03-15
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-13 of 13 references · Page 1 of 1
CITED BY
Showing 1-2 of 2 citing papers · Page 1 of 1